Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized; Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following MetastatectomyCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOGStatus: ActiveReview Status: Available to Open
